Recursion Pharmaceuticals Inc - Class A Shares Close the Day 15.3% Higher - Daily Wrap
The company saw its shares close the day 15.3% higher than yesterday, with trading volume higher than its 30 day average.
Jun 17, 2022 by Kwhen Finance Editors
Recursion Pharmaceuticals Inc - Class A (RXRX) shares closed today 15.3% higher than it did at the end of yesterday. The stock is currently down 55.5% year-to-date, down 78.3% over the past 12 months, and down 75.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 rose 0.2%.
Trading Activity
- Shares traded as high as $7.77 and as low as $5.53 this week.
- Shares closed 82.2% below its 52-week high and 54.9% above its 52-week low.
- Trading volume this week was 5.5% lower than the 10-day average and 7.9% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 2.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
- The stock closed at 15.8% higher than its 5-day moving average, 17.8% higher than its 20-day moving average, and 3.6% higher than its 90-day moving average.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals Inc - Class A | 15.3 | -55.5 | -78.3 | -84.0 | 39.6 |
| Dow Jones Industrial Average | -0.2 | -17.0 | -10.0 | -18.5 | 0.6 |
| S&P 500 Index | 0.2 | -22.4 | -11.8 | -23.3 | 0.9 |
| Technology Industry | -2.5 | 94.7 | -3.3 | -4.7 | 111.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 81.7%
- The company's stock price performance over the past 12 months lags the peer average by 124.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals Inc - Class A | RXRX | 0 | -55.5 | -78.3 | -84.0 | 39.6 |
| Peer Avg | N/A | 0 | -30.6 | -34.9 | -35.6 | 3.5 |
| Ovid Therapeutics Inc | OVID | 0 | -42.4 | -58.5 | -60.3 | 6.7 |
| Oyster Point Pharma Inc | OYST | 0 | -79.8 | -81.2 | -82.0 | 7.4 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: